Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement

Neurological complications after transcatheter aortic valve replacement (TAVR) may be reduced with transcatheter cerebral embolic protection (TCEP). This study evaluated the safety and efficacy of TCEP during TAVR. Nineteen centers randomized 363 patients undergoing TAVR to a safety arm (n = 123), d...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of the American College of Cardiology Ročník 69; číslo 4; s. 367
Hlavní autoři:	Kapadia, Samir R, Kodali, Susheel, Makkar, Raj, Mehran, Roxana, Lazar, Ronald M, Zivadinov, Robert, Dwyer, Michael G, Jilaihawi, Hasan, Virmani, Renu, Anwaruddin, Saif, Thourani, Vinod H, Nazif, Tamim, Mangner, Norman, Woitek, Felix, Krishnaswamy, Amar, Mick, Stephanie, Chakravarty, Tarun, Nakamura, Mamoo, McCabe, James M, Satler, Lowell, Zajarias, Alan, Szeto, Wilson Y, Svensson, Lars, Alu, Maria C, White, Roseann M, Kraemer, Carlye, Parhizgar, Azin, Leon, Martin B, Linke, Axel
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 31.01.2017
Témata:	Aged Aged, 80 and over Aortic Valve - surgery Cognition Female Humans Intracranial Embolism - prevention & control Magnetic Resonance Imaging Male Safety Transcatheter Aortic Valve Replacement - methods Treatment Outcome transcatheter aortic valve replacement stroke cerebral embolic protection neuroimaging
ISSN:	1558-3597, 1558-3597
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Neurological complications after transcatheter aortic valve replacement (TAVR) may be reduced with transcatheter cerebral embolic protection (TCEP). This study evaluated the safety and efficacy of TCEP during TAVR. Nineteen centers randomized 363 patients undergoing TAVR to a safety arm (n = 123), device imaging (n = 121), and control imaging (n = 119). The primary safety endpoint consisted of major adverse cardiac and cerebrovascular events (MACCE) at 30 days, and the primary efficacy endpoint was reduction in new lesion volume in protected brain territories on magnetic resonance imaging scans at 2 to 7 days. Patients underwent neurocognitive assessments, and the debris captured was analyzed. The rate of MACCE (7.3%) was noninferior to the performance goal (18.3%, p < 0.001) and not statistically different from that of the control group (9.9%; p = 0.41). New lesion volume was 178.0 mm in control subjects and 102.8 mm in the device arm (p = 0.33). A post hoc multivariable analysis identified pre-existing lesion volume and valve type as predictors of new lesion volume. Strokes at 30 days were 9.1% in control subjects and 5.6% in patients with devices (p = 0.25) Neurocognitive function was similar in control subjects and patients with devices, but there was a correlation between lesion volume and neurocognitive decline (p = 0.0022). Debris found within filters in 99% of patients included thrombus, calcification, valve tissue, artery wall, and foreign material. TCEP was safe, captured embolic debris in 99% of patients, and did not change neurocognitive function. Reduction in new lesion volume on magnetic resonance scans was not statistically significant. (Cerebral Protection in Transcatheter Aortic Valve Replacement [SENTINEL]; NCT02214277).
AbstractList	Neurological complications after transcatheter aortic valve replacement (TAVR) may be reduced with transcatheter cerebral embolic protection (TCEP).BACKGROUNDNeurological complications after transcatheter aortic valve replacement (TAVR) may be reduced with transcatheter cerebral embolic protection (TCEP).This study evaluated the safety and efficacy of TCEP during TAVR.OBJECTIVESThis study evaluated the safety and efficacy of TCEP during TAVR.Nineteen centers randomized 363 patients undergoing TAVR to a safety arm (n = 123), device imaging (n = 121), and control imaging (n = 119). The primary safety endpoint consisted of major adverse cardiac and cerebrovascular events (MACCE) at 30 days, and the primary efficacy endpoint was reduction in new lesion volume in protected brain territories on magnetic resonance imaging scans at 2 to 7 days. Patients underwent neurocognitive assessments, and the debris captured was analyzed.METHODSNineteen centers randomized 363 patients undergoing TAVR to a safety arm (n = 123), device imaging (n = 121), and control imaging (n = 119). The primary safety endpoint consisted of major adverse cardiac and cerebrovascular events (MACCE) at 30 days, and the primary efficacy endpoint was reduction in new lesion volume in protected brain territories on magnetic resonance imaging scans at 2 to 7 days. Patients underwent neurocognitive assessments, and the debris captured was analyzed.The rate of MACCE (7.3%) was noninferior to the performance goal (18.3%, pnoninferior < 0.001) and not statistically different from that of the control group (9.9%; p = 0.41). New lesion volume was 178.0 mm3 in control subjects and 102.8 mm3 in the device arm (p = 0.33). A post hoc multivariable analysis identified pre-existing lesion volume and valve type as predictors of new lesion volume. Strokes at 30 days were 9.1% in control subjects and 5.6% in patients with devices (p = 0.25) Neurocognitive function was similar in control subjects and patients with devices, but there was a correlation between lesion volume and neurocognitive decline (p = 0.0022). Debris found within filters in 99% of patients included thrombus, calcification, valve tissue, artery wall, and foreign material.RESULTSThe rate of MACCE (7.3%) was noninferior to the performance goal (18.3%, pnoninferior < 0.001) and not statistically different from that of the control group (9.9%; p = 0.41). New lesion volume was 178.0 mm3 in control subjects and 102.8 mm3 in the device arm (p = 0.33). A post hoc multivariable analysis identified pre-existing lesion volume and valve type as predictors of new lesion volume. Strokes at 30 days were 9.1% in control subjects and 5.6% in patients with devices (p = 0.25) Neurocognitive function was similar in control subjects and patients with devices, but there was a correlation between lesion volume and neurocognitive decline (p = 0.0022). Debris found within filters in 99% of patients included thrombus, calcification, valve tissue, artery wall, and foreign material.TCEP was safe, captured embolic debris in 99% of patients, and did not change neurocognitive function. Reduction in new lesion volume on magnetic resonance scans was not statistically significant. (Cerebral Protection in Transcatheter Aortic Valve Replacement [SENTINEL]; NCT02214277).CONCLUSIONSTCEP was safe, captured embolic debris in 99% of patients, and did not change neurocognitive function. Reduction in new lesion volume on magnetic resonance scans was not statistically significant. (Cerebral Protection in Transcatheter Aortic Valve Replacement [SENTINEL]; NCT02214277). Neurological complications after transcatheter aortic valve replacement (TAVR) may be reduced with transcatheter cerebral embolic protection (TCEP). This study evaluated the safety and efficacy of TCEP during TAVR. Nineteen centers randomized 363 patients undergoing TAVR to a safety arm (n = 123), device imaging (n = 121), and control imaging (n = 119). The primary safety endpoint consisted of major adverse cardiac and cerebrovascular events (MACCE) at 30 days, and the primary efficacy endpoint was reduction in new lesion volume in protected brain territories on magnetic resonance imaging scans at 2 to 7 days. Patients underwent neurocognitive assessments, and the debris captured was analyzed. The rate of MACCE (7.3%) was noninferior to the performance goal (18.3%, p < 0.001) and not statistically different from that of the control group (9.9%; p = 0.41). New lesion volume was 178.0 mm in control subjects and 102.8 mm in the device arm (p = 0.33). A post hoc multivariable analysis identified pre-existing lesion volume and valve type as predictors of new lesion volume. Strokes at 30 days were 9.1% in control subjects and 5.6% in patients with devices (p = 0.25) Neurocognitive function was similar in control subjects and patients with devices, but there was a correlation between lesion volume and neurocognitive decline (p = 0.0022). Debris found within filters in 99% of patients included thrombus, calcification, valve tissue, artery wall, and foreign material. TCEP was safe, captured embolic debris in 99% of patients, and did not change neurocognitive function. Reduction in new lesion volume on magnetic resonance scans was not statistically significant. (Cerebral Protection in Transcatheter Aortic Valve Replacement [SENTINEL]; NCT02214277).
Author	Nazif, Tamim Satler, Lowell Zajarias, Alan Svensson, Lars Virmani, Renu Woitek, Felix Kapadia, Samir R McCabe, James M Zivadinov, Robert Dwyer, Michael G Parhizgar, Azin Anwaruddin, Saif Thourani, Vinod H Szeto, Wilson Y Mick, Stephanie White, Roseann M Chakravarty, Tarun Krishnaswamy, Amar Kodali, Susheel Jilaihawi, Hasan Mangner, Norman Linke, Axel Nakamura, Mamoo Kraemer, Carlye Makkar, Raj Alu, Maria C Lazar, Ronald M Leon, Martin B Mehran, Roxana
Author_xml	– sequence: 1 givenname: Samir R surname: Kapadia fullname: Kapadia, Samir R email: kapadis@ccf.org organization: Cleveland Clinic, Cleveland, Ohio. Electronic address: kapadis@ccf.org – sequence: 2 givenname: Susheel surname: Kodali fullname: Kodali, Susheel organization: Columbia University Medical Center, New York, New York – sequence: 3 givenname: Raj surname: Makkar fullname: Makkar, Raj organization: Cedars-Sinai Medical Center, Los Angeles, California – sequence: 4 givenname: Roxana surname: Mehran fullname: Mehran, Roxana organization: Mount Sinai School of Medicine, New York, New York – sequence: 5 givenname: Ronald M surname: Lazar fullname: Lazar, Ronald M organization: Columbia University Medical Center, New York, New York – sequence: 6 givenname: Robert surname: Zivadinov fullname: Zivadinov, Robert organization: Buffalo Neuroimaging Analysis Center, Buffalo, New York – sequence: 7 givenname: Michael G surname: Dwyer fullname: Dwyer, Michael G organization: Buffalo Neuroimaging Analysis Center, Buffalo, New York – sequence: 8 givenname: Hasan surname: Jilaihawi fullname: Jilaihawi, Hasan organization: NYU Langone Medical Center, New York, New York – sequence: 9 givenname: Renu surname: Virmani fullname: Virmani, Renu organization: CV Path Institute, Gaithersburg, Maryland – sequence: 10 givenname: Saif surname: Anwaruddin fullname: Anwaruddin, Saif organization: University of Pennsylvania, Philadelphia, Pennsylvania – sequence: 11 givenname: Vinod H surname: Thourani fullname: Thourani, Vinod H organization: Emory University, Atlanta, Georgia – sequence: 12 givenname: Tamim surname: Nazif fullname: Nazif, Tamim organization: Columbia University Medical Center, New York, New York – sequence: 13 givenname: Norman surname: Mangner fullname: Mangner, Norman organization: Herzzentrum Leipzig GmbH-Universitätsklinik, Leipzig, Germany – sequence: 14 givenname: Felix surname: Woitek fullname: Woitek, Felix organization: Herzzentrum Leipzig GmbH-Universitätsklinik, Leipzig, Germany – sequence: 15 givenname: Amar surname: Krishnaswamy fullname: Krishnaswamy, Amar organization: Cleveland Clinic, Cleveland, Ohio – sequence: 16 givenname: Stephanie surname: Mick fullname: Mick, Stephanie organization: Cleveland Clinic, Cleveland, Ohio – sequence: 17 givenname: Tarun surname: Chakravarty fullname: Chakravarty, Tarun organization: Cedars-Sinai Medical Center, Los Angeles, California – sequence: 18 givenname: Mamoo surname: Nakamura fullname: Nakamura, Mamoo organization: Cedars-Sinai Medical Center, Los Angeles, California – sequence: 19 givenname: James M surname: McCabe fullname: McCabe, James M organization: University of Washington, Seattle, Washington – sequence: 20 givenname: Lowell surname: Satler fullname: Satler, Lowell organization: Medstar Washington Hospital Center, Washington, DC – sequence: 21 givenname: Alan surname: Zajarias fullname: Zajarias, Alan organization: Washington University School of Medicine, St. Louis, Missouri – sequence: 22 givenname: Wilson Y surname: Szeto fullname: Szeto, Wilson Y organization: University of Pennsylvania, Philadelphia, Pennsylvania – sequence: 23 givenname: Lars surname: Svensson fullname: Svensson, Lars organization: Cleveland Clinic, Cleveland, Ohio – sequence: 24 givenname: Maria C surname: Alu fullname: Alu, Maria C organization: Columbia University Medical Center, New York, New York – sequence: 25 givenname: Roseann M surname: White fullname: White, Roseann M organization: Duke Clinical Research Institute, Durham, North Carolina – sequence: 26 givenname: Carlye surname: Kraemer fullname: Kraemer, Carlye organization: NAMSA, Minneapolis, Minnesota – sequence: 27 givenname: Azin surname: Parhizgar fullname: Parhizgar, Azin organization: Claret Medical, Inc., Santa Rosa, California – sequence: 28 givenname: Martin B surname: Leon fullname: Leon, Martin B organization: Columbia University Medical Center, New York, New York – sequence: 29 givenname: Axel surname: Linke fullname: Linke, Axel organization: Herzzentrum Leipzig GmbH-Universitätsklinik, Leipzig, Germany; Leipzig Heart Institute, Leipzig, Germany
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/27815101$$D View this record in MEDLINE/PubMed
BookMark	eNpNkEtLw0AUhQep2If-ARcySzep88hMJstS6wMKSqluw83ktqYkkzozEfz3Bqzg6hw-Dt_iTMnIdQ4JueZszhnXd4f5Aaydi6EPYM6EPCMTrpRJpMqz0b8-JtMQDowxbXh-QcYiM1wNjgnZvPouoo115-hiD7ULkS7RY-mhoau27Jo6tPS-97Xb060HFyzED4zo6aLzsbb0HZovpBs8NmCxRRcvyfkOmoBXp5yRt4fVdvmUrF8en5eLdWKVTGMCKRMGc7QMBUeptWbVgPJSSshQZ2ggK4VUAqQ0qVVstwPGMlbKSqe6MmJGbn-9R9999hhi0dbBYtOAw64PBTdSZ1IYlQ_Tm9O0L1usiqOvW_Dfxd8P4geNSGHZ
CitedBy_id	crossref_primary_10_1016_j_jjcc_2019_02_022 crossref_primary_10_1161_CIRCIMAGING_119_010162 crossref_primary_10_1080_24748706_2019_1596336 crossref_primary_10_1016_j_amjcard_2017_10_012 crossref_primary_10_1080_17434440_2020_1789456 crossref_primary_10_1080_17434440_2022_2129009 crossref_primary_10_1177_10892532231173074 crossref_primary_10_1002_ccd_28374 crossref_primary_10_1002_ccd_30452 crossref_primary_10_1016_j_jcin_2020_05_039 crossref_primary_10_1016_j_amjcard_2020_10_038 crossref_primary_10_1016_j_jcin_2018_03_016 crossref_primary_10_1002_ccd_30697 crossref_primary_10_1016_j_jcin_2017_10_041 crossref_primary_10_1016_j_jcin_2018_07_025 crossref_primary_10_1007_s12928_021_00823_1 crossref_primary_10_1016_j_jscai_2022_100375 crossref_primary_10_1016_j_pcad_2022_04_001 crossref_primary_10_3390_jcm12165299 crossref_primary_10_1007_s11886_024_02035_4 crossref_primary_10_1097_HCR_0000000000000301 crossref_primary_10_1016_j_cjca_2020_05_025 crossref_primary_10_57264_cer_2023_0010 crossref_primary_10_1002_ccd_29105 crossref_primary_10_1038_s41598_025_99173_8 crossref_primary_10_1097_CRD_0000000000000674 crossref_primary_10_1111_jocs_16722 crossref_primary_10_1097_CRD_0000000000000797 crossref_primary_10_1016_j_carrev_2020_03_031 crossref_primary_10_1093_ehjci_jeab142 crossref_primary_10_1016_j_jscai_2023_101180 crossref_primary_10_1053_j_jvca_2025_04_026 crossref_primary_10_1016_j_amjcard_2023_04_031 crossref_primary_10_1093_eurheartj_ehy880 crossref_primary_10_1002_ccd_27398 crossref_primary_10_1016_j_carrev_2023_01_008 crossref_primary_10_1093_eurheartj_ehaf569 crossref_primary_10_1016_j_jcin_2025_06_019 crossref_primary_10_1093_eurheartj_ehaa799 crossref_primary_10_1016_j_jacc_2024_06_018 crossref_primary_10_1016_j_ahj_2017_12_008 crossref_primary_10_1016_j_carrev_2019_11_014 crossref_primary_10_1161_CIRCINTERVENTIONS_117_006208 crossref_primary_10_1016_j_cpcardiol_2022_101127 crossref_primary_10_1038_nrcardio_2017_116 crossref_primary_10_1016_j_jcin_2018_07_016 crossref_primary_10_1016_j_ijcard_2024_132085 crossref_primary_10_1016_j_jacc_2018_02_065 crossref_primary_10_1161_CIRCINTERVENTIONS_117_006322 crossref_primary_10_1016_j_jccase_2023_06_011 crossref_primary_10_1155_2020_2582938 crossref_primary_10_1016_j_amjcard_2021_04_038 crossref_primary_10_1016_j_carrev_2018_09_016 crossref_primary_10_1016_j_anclin_2019_08_014 crossref_primary_10_1016_j_shj_2023_100169 crossref_primary_10_1161_CIRCINTERVENTIONS_118_007605 crossref_primary_10_1161_CIR_0000000000000885 crossref_primary_10_1016_j_jvs_2017_11_098 crossref_primary_10_1016_j_jaccas_2020_09_036 crossref_primary_10_1016_j_jcin_2017_05_005 crossref_primary_10_1080_24748706_2020_1866788 crossref_primary_10_1093_eurheartj_ehz948 crossref_primary_10_3390_jcm11133902 crossref_primary_10_1080_00015385_2022_2072053 crossref_primary_10_1080_24748706_2017_1362609 crossref_primary_10_12688_f1000research_11906_1 crossref_primary_10_1016_j_shj_2023_100178 crossref_primary_10_1155_2023_5563121 crossref_primary_10_1016_j_amjcard_2024_02_013 crossref_primary_10_1002_ccd_28956 crossref_primary_10_1056_NEJMe2503640 crossref_primary_10_1080_14779072_2024_2445256 crossref_primary_10_1080_24748706_2017_1362610 crossref_primary_10_1056_NEJMoa2204961 crossref_primary_10_3390_jcm13237437 crossref_primary_10_1136_bmjopen_2020_042587 crossref_primary_10_1002_ccd_30340 crossref_primary_10_3390_jcm11072003 crossref_primary_10_1016_j_ijcard_2017_09_158 crossref_primary_10_1016_j_jscai_2023_100631 crossref_primary_10_1016_j_jstrokecerebrovasdis_2023_107054 crossref_primary_10_1007_s12325_017_0560_5 crossref_primary_10_1161_JAHA_118_009005 crossref_primary_10_1016_j_avsg_2021_12_075 crossref_primary_10_1016_j_amjcard_2022_06_026 crossref_primary_10_1093_eurheartj_suab110 crossref_primary_10_3390_jcm14061844 crossref_primary_10_1016_j_mayocpiqo_2025_100651 crossref_primary_10_1016_j_hrcr_2019_10_020 crossref_primary_10_1053_j_semtcvs_2018_09_026 crossref_primary_10_1111_joic_12372 crossref_primary_10_1111_imj_14071 crossref_primary_10_1016_j_jcin_2022_12_009 crossref_primary_10_1016_j_jcin_2017_12_018 crossref_primary_10_1186_s13063_023_07766_3 crossref_primary_10_1016_j_jacc_2019_12_038 crossref_primary_10_1111_eci_14166 crossref_primary_10_1016_j_jscai_2023_101031 crossref_primary_10_1093_eurheartj_ehac385 crossref_primary_10_1097_JS9_0000000000000456 crossref_primary_10_1007_s00392_019_01565_0 crossref_primary_10_1136_heartjnl_2018_313511 crossref_primary_10_1016_j_carrev_2018_02_009 crossref_primary_10_1016_j_jacc_2019_04_035 crossref_primary_10_1016_j_jtcvs_2017_02_009 crossref_primary_10_1161_STROKEAHA_116_015915 crossref_primary_10_1016_j_ijcard_2025_133804 crossref_primary_10_1007_s12325_018_0716_y crossref_primary_10_1016_j_jjcc_2019_01_013 crossref_primary_10_1080_00015385_2021_1909276 crossref_primary_10_1136_heartjnl_2025_326208 crossref_primary_10_1016_j_jaccas_2025_103768 crossref_primary_10_1016_j_tcm_2017_08_004 crossref_primary_10_1136_bmjopen_2018_022329 crossref_primary_10_1053_j_jvca_2018_11_011 crossref_primary_10_1177_1556984519892242 crossref_primary_10_1161_CIRCINTERVENTIONS_121_011358 crossref_primary_10_1080_24748706_2019_1639234 crossref_primary_10_1007_s00392_022_01997_1 crossref_primary_10_1161_CIRCULATIONAHA_120_052874 crossref_primary_10_1016_j_jcin_2020_06_030 crossref_primary_10_1016_j_jacc_2016_10_036 crossref_primary_10_1016_j_rec_2021_06_015 crossref_primary_10_1111_1744_1633_12342 crossref_primary_10_1002_ccd_70146 crossref_primary_10_1016_j_carrev_2019_04_023 crossref_primary_10_1053_j_jvca_2021_11_016 crossref_primary_10_1093_ehjcr_ytab130 crossref_primary_10_3390_jcm12041549 crossref_primary_10_1007_s12928_025_01128_3 crossref_primary_10_1007_s00059_017_4585_y crossref_primary_10_1016_j_jtcvs_2018_10_112 crossref_primary_10_1177_00033197241239687 crossref_primary_10_1016_j_jtcvs_2018_05_114 crossref_primary_10_3390_jcm10081789 crossref_primary_10_1001_jama_2019_8613 crossref_primary_10_1631_jzus_B2200444 crossref_primary_10_1001_jama_2019_7525 crossref_primary_10_1016_j_carrev_2019_10_013 crossref_primary_10_1080_03007995_2020_1808453 crossref_primary_10_1016_j_jaccas_2020_06_005 crossref_primary_10_1016_j_pcad_2021_11_003 crossref_primary_10_3389_fcvm_2019_00073 crossref_primary_10_1016_j_jcin_2017_06_037 crossref_primary_10_1016_j_tcm_2018_01_007 crossref_primary_10_1111_jocs_15695 crossref_primary_10_1007_s00398_017_0160_3 crossref_primary_10_1016_j_amjcard_2022_09_002 crossref_primary_10_3389_fcvm_2024_1205943 crossref_primary_10_1016_j_amjcard_2025_09_007 crossref_primary_10_1002_ccd_31487 crossref_primary_10_1093_ehjcr_ytaa392 crossref_primary_10_1097_HCO_0000000000000414 crossref_primary_10_1093_ejcts_ezz126 crossref_primary_10_1016_j_amjcard_2020_06_032 crossref_primary_10_1016_j_ccl_2019_09_007 crossref_primary_10_1016_j_amjcard_2021_03_010 crossref_primary_10_3389_fcvm_2022_958732 crossref_primary_10_3390_jcm11082190 crossref_primary_10_1016_j_iccl_2019_08_007 crossref_primary_10_1136_heartjnl_2019_316331 crossref_primary_10_1161_JAHA_117_008463 crossref_primary_10_2174_1381612826666200413083746 crossref_primary_10_3390_jcm14134677 crossref_primary_10_1161_JAHA_122_028890 crossref_primary_10_1007_s40119_020_00198_z crossref_primary_10_3390_jpm12071056 crossref_primary_10_1002_ccd_29842 crossref_primary_10_1038_s41598_025_98828_w crossref_primary_10_1161_JAHA_121_023561 crossref_primary_10_1161_JAHA_116_005314 crossref_primary_10_1016_j_jcin_2018_03_001 crossref_primary_10_3390_life13091819 crossref_primary_10_1007_s00398_020_00361_7 crossref_primary_10_1016_j_jcin_2017_12_003 crossref_primary_10_1016_j_ahj_2025_08_006 crossref_primary_10_1161_JAHA_123_030587 crossref_primary_10_3390_jcdd10070279 crossref_primary_10_1016_j_tcm_2017_08_013 crossref_primary_10_1007_s11748_022_01785_8 crossref_primary_10_1016_j_cjca_2024_11_002 crossref_primary_10_1161_STROKEAHA_124_047149 crossref_primary_10_1093_ejcts_ezab093 crossref_primary_10_1097_MJT_0000000000001413 crossref_primary_10_1097_CRD_0000000000000785 crossref_primary_10_1177_19418744231225680 crossref_primary_10_1111_jocs_16417 crossref_primary_10_17116_hirurgia2024122150 crossref_primary_10_1111_jocs_15355 crossref_primary_10_1002_ccd_27323 crossref_primary_10_1161_CIRCULATIONAHA_121_054902 crossref_primary_10_3389_fcvm_2022_971762 crossref_primary_10_1007_s40119_024_00359_4 crossref_primary_10_1016_j_ijcard_2017_03_003 crossref_primary_10_1016_j_jcin_2019_11_017 crossref_primary_10_1016_j_ahj_2017_06_007 crossref_primary_10_1016_j_rec_2017_09_014 crossref_primary_10_1016_j_jacc_2017_02_069 crossref_primary_10_1016_j_amjcard_2020_12_048 crossref_primary_10_1161_CIRCINTERVENTIONS_118_007546 crossref_primary_10_1161_CIRCULATIONAHA_122_059512 crossref_primary_10_1016_j_jcin_2019_04_052 crossref_primary_10_1016_j_jcin_2020_11_025 crossref_primary_10_1016_j_ahj_2022_02_004 crossref_primary_10_1016_j_avsg_2018_06_035 crossref_primary_10_3390_jcm9124118 crossref_primary_10_1016_j_avsg_2020_01_077 crossref_primary_10_1016_j_crmic_2025_100102 crossref_primary_10_1093_eurheartj_ehx390 crossref_primary_10_1016_j_jacc_2024_05_055 crossref_primary_10_1016_j_jjcc_2020_07_025 crossref_primary_10_1161_CIRCINTERVENTIONS_119_008231 crossref_primary_10_1161_JAHA_125_042147 crossref_primary_10_3390_jcm13237256 crossref_primary_10_1016_j_tcm_2018_02_001 crossref_primary_10_3390_jpm12020320 crossref_primary_10_1002_ccd_28521 crossref_primary_10_1093_eurheartj_ehy244 crossref_primary_10_1080_24748706_2020_1797256 crossref_primary_10_1016_j_jcin_2018_05_011 crossref_primary_10_1016_j_jcin_2020_03_042 crossref_primary_10_1080_24748706_2020_1716125 crossref_primary_10_1002_ejhf_1141 crossref_primary_10_1161_JAHA_120_019512 crossref_primary_10_1016_j_iccl_2023_06_002 crossref_primary_10_1016_j_jstrokecerebrovasdis_2019_104455 crossref_primary_10_1016_j_jcin_2017_07_032 crossref_primary_10_3390_jcm8020280 crossref_primary_10_1053_j_jvca_2017_08_034 crossref_primary_10_3390_hearts1020005 crossref_primary_10_1016_j_iccl_2021_06_008 crossref_primary_10_1016_j_iccl_2021_06_006 crossref_primary_10_3389_fcvm_2022_892956 crossref_primary_10_1016_j_jacc_2017_06_064 crossref_primary_10_1080_14779072_2020_1778465 crossref_primary_10_1016_j_shj_2023_100202 crossref_primary_10_1097_CRD_0000000000000849 crossref_primary_10_1007_s11065_022_09548_1 crossref_primary_10_1016_j_amjcard_2022_03_018 crossref_primary_10_1055_s_0041_1726330 crossref_primary_10_1016_j_jaccas_2020_03_010 crossref_primary_10_1016_j_jopan_2018_12_006 crossref_primary_10_1055_s_0039_1688483 crossref_primary_10_1007_s40119_017_0100_z crossref_primary_10_1016_j_cpcardiol_2021_100961 crossref_primary_10_1016_j_amjcard_2023_01_019 crossref_primary_10_1161_STROKEAHA_120_033984 crossref_primary_10_1097_HCO_0000000000000609 crossref_primary_10_3389_fcvm_2018_00150 crossref_primary_10_1001_jamainternmed_2019_6767 crossref_primary_10_1007_s12181_018_0298_6 crossref_primary_10_1136_heartjnl_2023_323359 crossref_primary_10_1016_j_amjcard_2021_08_004 crossref_primary_10_1016_j_jacadv_2024_100839 crossref_primary_10_1002_ccd_26937 crossref_primary_10_1016_j_athoracsur_2018_11_013 crossref_primary_10_1186_s12872_024_04097_2 crossref_primary_10_1016_j_jacc_2021_02_038 crossref_primary_10_1007_s11886_020_01335_9 crossref_primary_10_1038_s41598_021_98265_5 crossref_primary_10_1080_17434440_2017_1347038 crossref_primary_10_1016_j_carrev_2018_04_021 crossref_primary_10_1016_j_jcin_2018_05_030 crossref_primary_10_1016_j_hrcr_2021_06_008 crossref_primary_10_1080_14779072_2020_1833717 crossref_primary_10_1016_j_athoracsur_2021_12_032 crossref_primary_10_1001_jamainternmed_2019_6763 crossref_primary_10_1016_j_iccl_2018_03_004 crossref_primary_10_1016_j_jcin_2020_11_011 crossref_primary_10_1016_j_carrev_2020_09_016 crossref_primary_10_1016_j_hrcr_2019_08_012 crossref_primary_10_1111_jce_15160 crossref_primary_10_1016_j_cjca_2022_11_008 crossref_primary_10_1016_j_jcin_2018_04_004 crossref_primary_10_3390_medicina57070711 crossref_primary_10_1093_eurheartj_ehab213 crossref_primary_10_1155_2020_3070427 crossref_primary_10_1161_CIRCINTERVENTIONS_117_005206 crossref_primary_10_1007_s12181_017_0191_8 crossref_primary_10_1016_j_jcin_2023_12_033 crossref_primary_10_3390_jcdd12010005 crossref_primary_10_1016_j_jacc_2018_07_093 crossref_primary_10_1016_j_amjcard_2022_06_010 crossref_primary_10_1161_CIRCRESAHA_121_318040 crossref_primary_10_1093_eurheartj_ehab212 crossref_primary_10_1016_j_cpcardiol_2023_101675 crossref_primary_10_1016_j_shj_2022_100070 crossref_primary_10_1016_j_amjcard_2023_05_040 crossref_primary_10_1053_j_jvca_2017_02_051 crossref_primary_10_1016_j_shj_2024_100353 crossref_primary_10_1161_JAHA_120_019604 crossref_primary_10_1016_j_amjcard_2021_01_023 crossref_primary_10_1016_j_jcin_2023_10_021 crossref_primary_10_1016_j_jcin_2017_04_014 crossref_primary_10_1080_24748706_2018_1539281 crossref_primary_10_1016_j_jstrokecerebrovasdis_2022_106605 crossref_primary_10_1016_j_jacep_2019_11_017 crossref_primary_10_1111_jocs_16007 crossref_primary_10_1080_00015385_2019_1572959 crossref_primary_10_1161_CIRCINTERVENTIONS_121_011756 crossref_primary_10_1016_j_jcin_2018_06_018 crossref_primary_10_1080_24748706_2020_1845918 crossref_primary_10_1016_j_amjcard_2023_01_040 crossref_primary_10_1080_08998280_2018_1499294 crossref_primary_10_4103_heartviews_heartviews_25_22 crossref_primary_10_1016_j_hrcr_2021_01_009 crossref_primary_10_1016_j_hlc_2021_06_467 crossref_primary_10_1093_eurheartj_ehy847 crossref_primary_10_1093_ejcts_ezx457 crossref_primary_10_1161_CIRCINTERVENTIONS_118_006826 crossref_primary_10_1016_j_jcin_2020_03_004 crossref_primary_10_1016_j_jcmg_2017_06_005 crossref_primary_10_1016_j_jscai_2025_103608 crossref_primary_10_1161_STROKEAHA_117_017541 crossref_primary_10_1016_j_amjcard_2023_08_137 crossref_primary_10_1080_14779072_2021_1955346 crossref_primary_10_1111_jocs_16025 crossref_primary_10_1055_a_2664_7887 crossref_primary_10_1136_bcr_2020_238337 crossref_primary_10_1093_ejcts_ezx226 crossref_primary_10_1080_14779072_2024_2385989 crossref_primary_10_1016_j_jcin_2019_03_035 crossref_primary_10_1038_nrcardio_2017_82 crossref_primary_10_1161_JAHA_124_034298 crossref_primary_10_1016_j_athoracsur_2021_02_018 crossref_primary_10_1007_s00392_020_01732_8 crossref_primary_10_1161_JAHA_124_038869 crossref_primary_10_1016_j_amjcard_2021_01_042 crossref_primary_10_1111_joic_12562 crossref_primary_10_1016_j_jtcvs_2016_12_075 crossref_primary_10_1002_hsr2_1391 crossref_primary_10_1055_s_0040_1713424 crossref_primary_10_1016_j_jtcvs_2022_01_053 crossref_primary_10_1016_j_jacc_2016_12_002 crossref_primary_10_2459_JCM_0000000000001104 crossref_primary_10_3389_fcvm_2020_00149 crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_105665 crossref_primary_10_1213_ANE_0000000000007087 crossref_primary_10_1016_j_jscai_2025_103867 crossref_primary_10_1038_s41569_024_01076_0 crossref_primary_10_1016_j_ancard_2019_09_022 crossref_primary_10_1016_j_jcin_2020_09_047 crossref_primary_10_1007_s12471_020_01380_7 crossref_primary_10_1016_j_cpcardiol_2024_102478 crossref_primary_10_1016_j_jaccas_2023_102031 crossref_primary_10_1161_CIRCINTERVENTIONS_118_007135 crossref_primary_10_1186_s12872_023_03338_0 crossref_primary_10_1016_j_jacc_2018_08_2172 crossref_primary_10_3389_fcvm_2025_1528071 crossref_primary_10_1111_joic_12573 crossref_primary_10_1055_s_0041_1730117 crossref_primary_10_3389_fcvm_2018_00104 crossref_primary_10_1016_j_carrev_2021_05_010
ContentType	Journal Article
Contributor	Satler, Lowell Zajarias, Alan Greenbaum, Adam Wong, Shing-Chiu Frerker, Christian Sharma, Samin McCabe, James Rovin, Joshua Mick, Stephanie Bergman, Geoffrey Kini, Annapoorna Kapadia, Samir Krishnaswamy, Amar Mahoney, Paul Lin, Lang Reisman, Mark Herrmann, Howard Morse, Andrew Linke, Axel Spriggs, Douglas Waksman, Ron O'Neill, William Stankewicz, Mark Loyalka, Pranav Al-Jilaihawi, Hasanian Nazif, Tamin Lim, D Scott Woitek, Felix Ragosta, Michael Devireddy, Chandan Babaliaros, Vasilis Rodriguez, Evelio Pichard, Augusto Don, Creighton Vallabhajosyula, Prashanth Thourani, Vinod Anwaruddin, Saif Tuzcu, E Murat Salemi, Arash Dangas, George Cohen, David Kar, Biswajit Kodali, Susheel Mangner, Norman Eng, Marvin Mavromatis, Kreton Giri, Jay Lasala, John Makkar, Raj Szeto, Wilson Smalling, Richard
Contributor_xml	– sequence: 1 givenname: Raj surname: Makkar fullname: Makkar, Raj – sequence: 2 givenname: Hasanian surname: Al-Jilaihawi fullname: Al-Jilaihawi, Hasanian – sequence: 3 givenname: Samir surname: Kapadia fullname: Kapadia, Samir – sequence: 4 givenname: Amar surname: Krishnaswamy fullname: Krishnaswamy, Amar – sequence: 5 givenname: E Murat surname: Tuzcu fullname: Tuzcu, E Murat – sequence: 6 givenname: Stephanie surname: Mick fullname: Mick, Stephanie – sequence: 7 givenname: Susheel surname: Kodali fullname: Kodali, Susheel – sequence: 8 givenname: Tamin surname: Nazif fullname: Nazif, Tamin – sequence: 9 givenname: Vinod surname: Thourani fullname: Thourani, Vinod – sequence: 10 givenname: Vasilis surname: Babaliaros fullname: Babaliaros, Vasilis – sequence: 11 givenname: Chandan surname: Devireddy fullname: Devireddy, Chandan – sequence: 12 givenname: Kreton surname: Mavromatis fullname: Mavromatis, Kreton – sequence: 13 givenname: Ron surname: Waksman fullname: Waksman, Ron – sequence: 14 givenname: Lowell surname: Satler fullname: Satler, Lowell – sequence: 15 givenname: Augusto surname: Pichard fullname: Pichard, Augusto – sequence: 16 givenname: Wilson surname: Szeto fullname: Szeto, Wilson – sequence: 17 givenname: Saif surname: Anwaruddin fullname: Anwaruddin, Saif – sequence: 18 givenname: Prashanth surname: Vallabhajosyula fullname: Vallabhajosyula, Prashanth – sequence: 19 givenname: Jay surname: Giri fullname: Giri, Jay – sequence: 20 givenname: Howard surname: Herrmann fullname: Herrmann, Howard – sequence: 21 givenname: Alan surname: Zajarias fullname: Zajarias, Alan – sequence: 22 givenname: John surname: Lasala fullname: Lasala, John – sequence: 23 givenname: Adam surname: Greenbaum fullname: Greenbaum, Adam – sequence: 24 givenname: William surname: O'Neill fullname: O'Neill, William – sequence: 25 givenname: Marvin surname: Eng fullname: Eng, Marvin – sequence: 26 givenname: Joshua surname: Rovin fullname: Rovin, Joshua – sequence: 27 givenname: Lang surname: Lin fullname: Lin, Lang – sequence: 28 givenname: Douglas surname: Spriggs fullname: Spriggs, Douglas – sequence: 29 givenname: Shing-Chiu surname: Wong fullname: Wong, Shing-Chiu – sequence: 30 givenname: Geoffrey surname: Bergman fullname: Bergman, Geoffrey – sequence: 31 givenname: Arash surname: Salemi fullname: Salemi, Arash – sequence: 32 givenname: Richard surname: Smalling fullname: Smalling, Richard – sequence: 33 givenname: Biswajit surname: Kar fullname: Kar, Biswajit – sequence: 34 givenname: Pranav surname: Loyalka fullname: Loyalka, Pranav – sequence: 35 givenname: D Scott surname: Lim fullname: Lim, D Scott – sequence: 36 givenname: Michael surname: Ragosta fullname: Ragosta, Michael – sequence: 37 givenname: Mark surname: Reisman fullname: Reisman, Mark – sequence: 38 givenname: James surname: McCabe fullname: McCabe, James – sequence: 39 givenname: Creighton surname: Don fullname: Don, Creighton – sequence: 40 givenname: Samin surname: Sharma fullname: Sharma, Samin – sequence: 41 givenname: Annapoorna surname: Kini fullname: Kini, Annapoorna – sequence: 42 givenname: George surname: Dangas fullname: Dangas, George – sequence: 43 givenname: Paul surname: Mahoney fullname: Mahoney, Paul – sequence: 44 givenname: Andrew surname: Morse fullname: Morse, Andrew – sequence: 45 givenname: Mark surname: Stankewicz fullname: Stankewicz, Mark – sequence: 46 givenname: Evelio surname: Rodriguez fullname: Rodriguez, Evelio – sequence: 47 givenname: Axel surname: Linke fullname: Linke, Axel – sequence: 48 givenname: Norman surname: Mangner fullname: Mangner, Norman – sequence: 49 givenname: Felix surname: Woitek fullname: Woitek, Felix – sequence: 50 givenname: Christian surname: Frerker fullname: Frerker, Christian – sequence: 51 givenname: David surname: Cohen fullname: Cohen, David
Copyright	Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Copyright_xml	– notice: Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
CorporateAuthor	SENTINEL Trial Investigators
CorporateAuthor_xml	– name: SENTINEL Trial Investigators
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1016/j.jacc.2016.10.023
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine
EISSN	1558-3597
ExternalDocumentID	27815101
Genre	Randomized Controlled Trial Journal Article
GroupedDBID	--- --K --M .1- .FO .~1 0R~ 18M 1B1 1P~ 1~. 1~5 2WC 4.4 457 4G. 53G 5GY 5RE 5VS 6PF 7-5 71M 8P~ AABNK AABVL AACTN AAEDT AAEDW AAIKJ AAKUH AAOAW AAQFI AAXUO ABBQC ABFNM ABFRF ABLJU ABMAC ABMZM ABOCM ACGFO ACGFS ACIUM ACJTP ACPRK ADBBV ADEZE ADVLN AEFWE AEKER AENEX AEVXI AEXQZ AFCTW AFETI AFRAH AFRHN AFTJW AGYEJ AHMBA AITUG AJRQY AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BLXMC CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FNPLU G-Q GBLVA GX1 H13 HVGLF IHE IXB J1W K-O KQ8 L7B MO0 N9A NPM O-L O9- OA. OAUVE OK1 OL~ OZT P-8 P-9 P2P PC. PQQKQ PROAC Q38 RIG ROL RPZ SCC SDF SDG SDP SES SSZ TR2 UNMZH UV1 W8F WH7 WOQ WOW YYM YZZ Z5R 7X8 ACVFH ADCNI AEUPX AFPUW AIGII AKBMS AKYEP EFKBS EFLBG ~HD
ID	FETCH-LOGICAL-c534t-a4028e9ec0e21e36660d4029b33a7e67e8a7b2352a3384c50ffa0070b3d646d82
IEDL.DBID	7X8
ISICitedReferencesCount	397
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000392994500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1558-3597
IngestDate	Thu Oct 02 14:34:24 EDT 2025 Thu Apr 03 06:49:58 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	4
Keywords	transcatheter aortic valve replacement stroke cerebral embolic protection neuroimaging
Language	English
License	Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c534t-a4028e9ec0e21e36660d4029b33a7e67e8a7b2352a3384c50ffa0070b3d646d82
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3
OpenAccessLink	https://www.clinicalkey.com/#!/content/1-s2.0-S0735109716367687
PMID	27815101
PQID	1836732859
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_1836732859 pubmed_primary_27815101
PublicationCentury	2000
PublicationDate	2017-01-31
PublicationDateYYYYMMDD	2017-01-31
PublicationDate_xml	– month: 01 year: 2017 text: 2017-01-31 day: 31
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Journal of the American College of Cardiology
PublicationTitleAlternate	J Am Coll Cardiol
PublicationYear	2017
References	27815102 - J Am Coll Cardiol. 2017 Jan 31;69(4):378-380
References_xml	– reference: 27815102 - J Am Coll Cardiol. 2017 Jan 31;69(4):378-380
SSID	ssj0006819
Score	2.660861
Snippet	Neurological complications after transcatheter aortic valve replacement (TAVR) may be reduced with transcatheter cerebral embolic protection (TCEP). This study... Neurological complications after transcatheter aortic valve replacement (TAVR) may be reduced with transcatheter cerebral embolic protection...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	367
SubjectTerms	Aged Aged, 80 and over Aortic Valve - surgery Cognition Female Humans Intracranial Embolism - prevention & control Magnetic Resonance Imaging Male Safety Transcatheter Aortic Valve Replacement - methods Treatment Outcome
Title	Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement
URI	https://www.ncbi.nlm.nih.gov/pubmed/27815101 https://www.proquest.com/docview/1836732859
Volume	69
WOSCitedRecordID	wos000392994500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEF7Uinjx_agvVvC62mw2u5uTFG3xYEsRld7CZrORSpvUpvb3O5Ok9CQIXnIIJITdyXzfPPYbQm5kqkwidcgCz4RMAGVmIU8dC7WLhRGcK1tK5j-rfl8Ph-GgTrgVdVvl0ieWjjrJLebI78D0JArLBOH99Ivh1CisrtYjNNZJwwcqgy1darhSC5e6HOwBkKmZD8y5PjRT9Xd9GosShp68xe4uHFf0G8Usoaa7-9-P3CM7Ncmk7coq9smayw7IVq8uox-Sl0GlzgB7QtsfZgQUkT64GdaQx7QzifPxqJjQx_IEIy3RrFR3hS2g7RxfSt_NeOEosHfMwmOC8Yi8dTuvD0-sHq7AbOCLOTMQOGoXOtty3HM-RDGtBG6Fse8b5aRy2qiYAz0zEMQKG7TS1KA2UOwnUshE82OykeWZOyXUSiViD6iidIiJOhYq8FzqWfAlhidpk1wvVysC48WKhMlc_l1Eq_VqkpNqyaNppbIRcaU9dBhnf3j6nGxzhNuWB5hyQRop_LrukmzaxXxUzK5Kq4Brf9D7AXviwF0
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Protection+Against+Cerebral+Embolism+During+Transcatheter+Aortic+Valve+Replacement&rft.jtitle=Journal+of+the+American+College+of+Cardiology&rft.au=Kapadia%2C+Samir+R&rft.au=Kodali%2C+Susheel&rft.au=Makkar%2C+Raj&rft.au=Mehran%2C+Roxana&rft.date=2017-01-31&rft.issn=1558-3597&rft.eissn=1558-3597&rft.volume=69&rft.issue=4&rft.spage=367&rft_id=info:doi/10.1016%2Fj.jacc.2016.10.023&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1558-3597&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1558-3597&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1558-3597&client=summon